Effectiveness of long-term human growth hormone therapy for short stature in children with growth hormone deficiency.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000365:Age Determination by Skeleton; D000917:Antibody Formation; D001798:Blood Proteins; D001827:Body Height; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006128:Growth / Q000187:drug effects*; D006130:Growth Disorders / Q000188:drug therapy; D013006:Growth Hormone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy*; D007328:Insulin; D007455:Iodine / Q000097:blood; D008134:Long-Term Care; D008297:Male; D008797:Metyrapone; D010901:Pituitary Function Tests; D011485:Protein Binding; D011863:Radioimmunoassay; D012885:Skinfold Thickness
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D001798:Blood Proteins; D007328:Insulin; D013006:Growth Hormone; D007455:Iodine; D008797:Metyrapone